# US 2022/0031645 A1 · Aqueous formulation comprising paracetamol and ibuprofen

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031645 A1
- Document ID: US20220031645A1
- Status: Published application
- Kind: A1
- Application number: 17/502,899
- Filed: 2021-10-15
- Published: 2022-02-03
- Earliest claimed: 2014-07-18
- Assignees: Hyloris Pharmaceuticals SA
- Applicants: Hyloris Pharmaceuticals SA
- Inventors: Thomas Jacobsen
- Web page: https://patentgrep.com/patent/US20220031645A1

## CPC

- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61J 1/10: Bag-type containers
- A61J 1/2093: {Containers having several compartments for products to be mixed}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61M 5/1407: {Infusion of two or more substances}
- A61M 5/19: having more than one chamber
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An aqueous ibuprofen and paracetamol composition has a pH 6.3-7.3. The composition can be used as a medicament, especially for the treatment of pain and/or inflammation. The composition can be formulated for intravenous injection.

## Claims

### Claim 1

An aqueous composition, comprising ibuprofen and paracetamol, wherein the pH of said composition is 6.3 to 7.3, and wherein the composition is in a form suitable for intravenous injection or infusion.

### Claim 2 (depends on 1)

The composition according to claim 1, comprising 2.8 to 3.2 mg ibuprofen and 9.8 to 10.2 mg paracetamol expressed per ml of said composition.

### Claim 3 (depends on 1)

The composition according to claim 1, further comprising an isotonic agent.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein said composition has a storage stability of at least 6 months.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein said composition has a dissolved oxygen content below 2 ppm.

### Claim 6 (depends on 2)

The composition according to claim 2, comprising 3 mg ibuprofen and 10 mg paracetamol expressed per ml of said composition.

### Claim 7 (depends on 3)

The composition according to claim 3, wherein the isotonic agent is mannitol.

### Claim 8 (depends on 4)

The composition according to claim 4, wherein the composition has a storage stability of at least 12 months.
